Soumia ABIDE

Experience

• 

  Laboratoires Pharmalliance

  Jan 2021 - Apr 2021

  • Regulatory Affairs

    Apr 2021 - Apr 2021

  • Manufacturing & Quality Assurance

    Mar 2021 - Mar 2021

  • R&D and Quality Control

    Jan 2021 - Mar 2021
• 

  Agence Nationale des Produits Pharmaceutiques

  May 2021 - Sept 2021

  Pharmacotoxicology Department / National Agency of Pharmaceutical Products.

  InVivo assessment of the anti-eczematous activity of emullgels formulated with curcumin as a natural active substance, essential oils and vegetable oils, and its comparison with a reference chemical treatment hydrocortisone.Curcumin is a phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmacologic properties.The InVivo study was conducted using BALB-C laboratory mice.

• 

  وزارة الصناعة الصيدلانية

  Jan 2022 - May 2022

  Ministry of Pharmaceutical Industry

  Internship at The Department of Pharmaceutical activities and Regulation:Overall view of the regulation governing:-Import activity of raw materials, pharmaceutical finished products and medical devices (various technical import visas such as : Provisional Import Program PPI, Import certificat of psychotropic drugs COI, Regulation certificate...)-Distribution activity of pharmaceutical products and medical devices.-Incineration of expired or non-compliant finished products and raw materials. عرض أقل

• 

  Groupe Saidal SPA

  May 2022 - now

  SAIDAL is a Group of 09 manufacturing sites and 03 distribution sites with two annexes : R&D center and Bioequivalence center.The Regulatory Affairs Department work closely together with the technical department of each manufacturing/distribution sites listed above in order to ensure the compliance within the pharma guidelines/ local regulatory requirements.Working closely together with the Medical Department with the aim of collecting data on adverse drug events occurring after the use of our products, assessment of the data by the PV department and their transmission to the CNPM and partners within the due dates according to the PV SOP and PV agreements. عرض أقل

  • QPPV & RA pharmacist

    Oct 2024 - now

  • Regulatory Affairs & Pharmacovigilance Pharmacist

    Oct 2022 - now

  • Regulatory Affairs Pharmacist

    May 2022 - Sept 2022